AI-powered drug response prediction for pet cancer
#44 of 55 therapeutics startups
▲ 1 since the last ranking
Ranked 6:02 AM PT · Thu, Nov 19
Listed
ImpriMed is a functional precision medicine company providing ex vivo drug sensitivity testing CRO services for hematologic malignancy drug development, using living primary patient cells and machine learning analytics.
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.